| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/03/2026 | ±2.3% | -7.0% | under-priced |
| 05/06/2026 | ±2.7% | +1.3% | over-priced |
| 02/10/2026 | ±2.4% | +8.5% | under-priced |
| 11/04/2025 | ±2.1% | +3.2% | under-priced |
| 08/05/2025 | ±2.4% | +0.2% | over-priced |
| 05/06/2025 | ±2.6% | +1.9% | over-priced |
| 02/11/2025 | ±1.9% | -5.4% | under-priced |
| 11/04/2024 | ±1.5% | -1.6% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $2.90 | $7.1B | $766M |
| Q1 FY2026 | $2.43 | $6.7B | $648M |
| Q4 FY2025 | — | $6.7B | $445M |
| Q3 FY2025 | $2.67 | $6.5B | $728M |
MAR (MAR) reports in 6 days, with the next report estimated for 11/02/2026. Across the last 8 reports, options priced an average ±2.3% earnings move while the stock actually moved 3.6% on average — the market has been roughly fair on MAR's earnings risk. Fundamentals into the print: EPS up 4.3% year-over-year, revenue up 4.8%. QuantLogix's live 5-factor engine currently reads MAR as a neutral at 54/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →